Potential Future Impact of a Partially Effective HIV Vaccine in a Southern African Setting

• Andrew N. Phillips ,

  * E-mail: andrew.phillips@ucl.ac.uk

  Affiliation Research Department of Infection & Population Health, University College London, London, United Kingdom

  ⨯
• Valentina Cambiano,

  Affiliation Research Department of Infection & Population Health, University College London, London, United Kingdom

  ⨯
• Fumiyo Nakagawa,

  Affiliation Research Department of Infection & Population Health, University College London, London, United Kingdom

  ⨯
• Deborah Ford,

  Affiliation Institute of Clinical Trials and Methodology, University College London, London, United Kingdom

  ⨯
• Jens D. Lundgren,

  Affiliation CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Edith Roset-Bahmanyar,

  Current address: Novartis Foundation for Sustainable Development, Basel, Switzerland

  Affiliation GlaxoSmithKline Vaccines, Wavre, Belgium

  ⨯
• François Roman,

  Affiliation GlaxoSmithKline Vaccines, Wavre, Belgium

  ⨯
• Thierry Van Effelterre

  Affiliation GlaxoSmithKline Vaccines, Wavre, Belgium

  ⨯